BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33226445)

  • 1. Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA).
    Hagelstein-Rotman M; Meier ME; Majoor BCJ; Cleven AHG; Dijkstra PDS; Hamdy NAT; van de Sande MAJ; Dekkers OM; Appelman-Dijkstra NM
    Calcif Tissue Int; 2021 Mar; 108(3):346-353. PubMed ID: 33226445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
    Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
    Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Risk of Breast Cancer at a Young Age in Women with Fibrous Dysplasia.
    Majoor BC; Boyce AM; Bovée JV; Smit VT; Collins MT; Cleton-Jansen AM; Dekkers OM; Hamdy NA; Dijkstra PS; Appelman-Dijkstra NM
    J Bone Miner Res; 2018 Jan; 33(1):84-90. PubMed ID: 28856726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark.
    Meier ME; Vágó E; Abrahamsen B; Dekkers OM; Horváth-Puhó E; Rejnmark L; Appelman-Dijkstra NM
    J Clin Endocrinol Metab; 2024 May; 109(6):1423-1432. PubMed ID: 38174586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome.
    Meier ME; Hagelstein-Rotman M; Majoor BCJ; Geels RES; Appelman-Dijkstra NM; Bravenboer N
    Bone; 2023 Apr; 169():116679. PubMed ID: 36652988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Bone Fractures in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History, and Risk Factors.
    Geels RES; Meier ME; Saikali A; Tsonaka R; Appelman-Dijkstra NM; Boyce AM
    J Bone Miner Res; 2022 Feb; 37(2):236-243. PubMed ID: 34668234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
    Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
    Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
    Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
    Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study.
    Meier ME; Hagelstein-Rotman M; van de Ven AC; Van der Geest ICM; Donker O; Pichardo SEC; Hissink Muller PCE; van der Meeren SW; Dorleijn DMJ; Winter EM; van de Sande MAJ; Appelman-Dijkstra NM
    Orphanet J Rare Dis; 2022 Dec; 17(1):439. PubMed ID: 36528764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
    Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
    Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
    Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome.
    Zhadina M; Roszko KL; Geels RES; de Castro LF; Collins MT; Boyce AM
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1482-1490. PubMed ID: 33512531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS).
    Vado Y; Manero-Azua A; Pereda A; Perez de Nanclares G
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38255009
    [No Abstract]   [Full Text] [Related]  

  • 14. Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study.
    Meier ME; Appelman-Dijkstra NM; Collins MT; Geels RES; Stanton RP; de Witte PB; Boyce AM; van de Sande MAJ
    J Bone Miner Res; 2023 Jul; 38(7):968-975. PubMed ID: 37102469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.
    Javaid MK; Boyce A; Appelman-Dijkstra N; Ong J; Defabianis P; Offiah A; Arundel P; Shaw N; Pos VD; Underhil A; Portero D; Heral L; Heegaard AM; Masi L; Monsell F; Stanton R; Dijkstra PDS; Brandi ML; Chapurlat R; Hamdy NAT; Collins MT
    Orphanet J Rare Dis; 2019 Jun; 14(1):139. PubMed ID: 31196103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
    Spencer TL; Watts L; Soni A; Pinedo-Villanueva R; Heegaard AM; Boyce AM; Javaid MK
    J Clin Endocrinol Metab; 2022 May; 107(6):e2258-e2266. PubMed ID: 35262711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome.
    Roszko KL; Guthrie L; Li X; Collins MT; de Castro LF; Boyce AM
    J Bone Miner Res; 2023 Mar; 38(3):443-450. PubMed ID: 36593655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
    Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
    Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
    van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.